deblan/covid-data
1
0
Fork 0
Code Issues Pull requests Projects Releases Wiki Activity

Update pfizer

Browse source
This commit is contained in:
Emmanuel Béziat 2021-05-27 19:26:30 +02:00
parent 6dbde3652f
commit 361bc4a87e
No known key found for this signature in database
GPG key ID: A81FB08FF1B339E6
1 changed files with 6 additions and 1 deletions
Show stats Download patch file Download diff file Expand all files Collapse all files

7
vaccins/pfizer.md
View file

@ -72,7 +72,7 @@
![Pfizer-BioNTech and AstraZeneca, Oxford Vaccine effectiveness in over 70s](../graphs/msedge_wHYBNSH4e2.jpg) ![Pfizer-BioNTech and AstraZeneca, Oxford Vaccine effectiveness in over 70s](../graphs/msedge_wHYBNSH4e2.jpg)
[Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England * [Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England
* [The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine](https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_w) — CDC, 18 Décembre 2020 * [The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine](https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_w) — CDC, 18 Décembre 2020
### Israël ### Israël
@ -83,8 +83,13 @@
Le vaccin Pfizer montre une bonne efficacité contre les variants B.1.1.7 (dit "anglais") et B.1.351 (dit "africain") Le vaccin Pfizer montre une bonne efficacité contre les variants B.1.1.7 (dit "anglais") et B.1.351 (dit "africain")
* [Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants](https://www.nejm.org/doi/10.1056/NEJMc2104974) — NEJM, 5 Mai 2021
* [BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans](https://www.nature.com/articles/s41586-021-03653-6) — Nature, 27 Mai 2021 * [BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans](https://www.nature.com/articles/s41586-021-03653-6) — Nature, 27 Mai 2021
## Autres études
* [BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting](https://www.nejm.org/doi/full/10.1056/NEJMoa2101765) — NEJM, 15 Avril 2021
## Autorisations et recommandations ## Autorisations et recommandations
| Pays / Zone | Document(s) | | Pays / Zone | Document(s) |